TickerFactsScreenerDevelopers

Celldex Therapeutics, Inc. (CLDX) — Cost of Revenue

Annual figures by fiscal year, from SEC filings.

2016: $1.60M2017: $700.0K2018: $700.0K2019: $100.0K2020: $200.0K2021: $100.0K2022: $100.0K2023: $300.0K2024: $200.0K2025: $200.0K$200.0K
2016Cost of Revenue (USD)2025
Fiscal YearCost of RevenueChange YoY
2025$200.0K+0.0%
2024$200.0K-33.3%
2023$300.0K+200.0%
2022$100.0K+0.0%
2021$100.0K-50.0%
2020$200.0K+100.0%
2019$100.0K-85.7%
2018$700.0K+0.0%
2017$700.0K-56.2%
2016$1.60M—